Mangalam Drugs And Organics
MANGALAM •NSE

Mangalam Drugs And Organics

₹29.400.18 (0.62%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
28.60
Today’s high
29.96
52 week low
22.80
52 week high
64.50
Open price
29.22
Previous close
29.22
Live volume
18,795
Lower circuit
26.30
Upper circuit
32.14

Fundamentals

Market Cap
₹46Cr
ROE
-43.33%
P/E Ratio(TTM)
--
EPS(TTM)
-24.07
P/B Ratio
0.57
Dividend Yield
0.00%
Industry P/E
40.71
Book Value
51.08
Debt to Equity
1.03
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹79.56Cr
+39.02%
-₹7.21Cr
+5.63%
-25031.2562.593.75
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+61%
Profit growthValue
1Y (TTM)+2%

About

Mangalam Drugs & Organics Limited is a premier Indian manufacturer of Active Pharmaceutical Ingredients (APIs), supplying world-class products to the pharmaceutical sector. The company's focused efforts are designed to provide a competitive edge in the ever-evolving pharmaceutical landscape. It prioritizes customer satisfaction and diligently follows regulatory requirements, ensuring its products have a positive impact on the industries it serves. Its state-of-the-art manufacturing sites at Vapi are mainly focused on producing advanced intermediates for APIs, in compliance with high quality benchmarks. A strong backward integration strategy for key raw materials is the foundation of its dominant position in the industry. The company also has a global presence, with its products available in countries like Italy, Russia, China, Turkey, Nigeria, and Pakistan.;
CEO/MD
Govardhan M Dhoot
Founded in
1972
NSE symbol
MANGALAM
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,520.30
+17.80 (0.71%)
L
    H
    19,010.9128.045.64
    PfizerPFIZER
    ₹3,893.30
    -24.60 (0.63%)
    L
      H
      17,930.5920.864.09
      ₹6,507.00
      -7.50 (0.12%)
      L
        H
        16,280.5091.6118.52
        Natco PharmaNATCOPHARM
        ₹808.95
        +4.60 (0.57%)
        L
          H
          15,772.8813.781.5
          Livesquawk •
          Mangalam Drugs defaults ₹15.57 crore loan to Bank of Maharashtra, Bank of Baroda. Loan overdue for over 30 days, impacting financial stability.
          2026
          5
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          14
          May
          Annual Result
          Release date
          15
          Jan
          Quarterly Result
          Release date
          2025
          20
          Nov
          Quarterly Result
          Release date
          13
          Nov
          Quarterly Result
          Release date
          7
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks